---
type: "Symbol"
title: "Aura Biosciences (AURA.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/AURA.US/topics.md"
symbol: "AURA.US"
parent: "https://longbridge.com/en/quote/AURA.US.md"
count: 1
datetime: "2026-03-08T04:22:40.900Z"
locales:
  - [en](https://longbridge.com/en/quote/AURA.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AURA.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AURA.US/topics.md)
---

# Aura Biosciences (AURA.US) — Community Discussions

### [【新股 IPO】AURA：从未有收入，能够超越吗？](https://longbridge.com/en/topics/2711207.md)

- Author: [阿浦美股](https://longbridge.com/en/profiles/6844605.md)
- Datetime: 2022-06-02T01:39:17.000Z
- Comments: 0
- 01 企业介绍 Aura Biosciences, Inc.（AURA）$Aura Biosciences(AURA.US) 是一家处于临床阶段的专注于眼部和泌尿肿瘤学的生物技术公司，公司的团队由在肿瘤学和眼科药物开发方面拥有丰富经验的生物制药专家组成，目标是利用公司的专有平台开发一类新的靶向疗法，为一系列具有高度未满足需求的癌症适应症提供有意义的治疗益处，以建立新的护理标准...

## References

- [Aura Biosciences (AURA.US)](https://longbridge.com/en/quote/AURA.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/AURA.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AURA.US/topics.md)